Xiaopeng Cui
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 4
- FOXO transcription factor regulation 3
- Oncology 16
- Cancer-related Molecular Pathways 9
- Co-authors
- Xianjuan Shen (4 shared papers)Song He (7 shared papers)Cuihua Lu (8 shared papers)Runzhou Ni (10 shared papers)Qing Ke (5 shared papers)Aiguo Shen (5 shared papers)Mudan Lu (5 shared papers)Chun Cheng (4 shared papers)
- Journals
- Medical Oncology (3 papers)Experimental and Molecular Pathology (3 papers)Pathology & Oncology Research (2 papers)Journal of Molecular Histology (2 papers)Bioscience Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaopeng Cui
34 papers receiving 667 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 244
- Molecular Biology 470
- Oncology 137
- Pathology and Forensic Medicine 78
- Hepatology 31
Countries citing papers authored by Xiaopeng Cui
This map shows the geographic impact of Xiaopeng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Cui more than expected).
Fields of papers citing papers by Xiaopeng Cui
This network shows the impact of papers produced by Xiaopeng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Cui. The network helps show where Xiaopeng Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopeng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 57 | |
| 2 | 2008 | 52 | |
| 3 | 2009 | 38 | |
| 4 | 2019 | 37 | |
| 5 | 2016 | 36 | |
| 6 | 2020 | 34 | |
| 7 | 2021 | 31 | |
| 8 | 2019 | 30 | |
| 9 | 2013 | 29 | |
| 10 | 2019 | 27 | |
| 11 | 2013 | 26 | |
| 12 | 2019 | 26 | |
| 13 | 2014 | 25 | |
| 14 | 2014 | 24 | |
| 15 | 2015 | 22 | |
| 16 | 2016 | 21 | |
| 17 | 2016 | 19 | |
| 18 | 2013 | 15 | |
| 19 | 2021 | 15 | |
| 20 | 2016 | 14 |
About Xiaopeng Cui
Xiaopeng Cui is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Cell Biology, having authored 35 papers that have together received 676 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (7 papers), Cancer Mechanisms and Therapy (5 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer, Lipids, and Metabolism (3 papers) and FOXO transcription factor regulation (3 papers). The work is most often cited by research in Cancer Research (244 citations), Molecular Biology (470 citations), Oncology (137 citations), Pathology and Forensic Medicine (78 citations) and Hepatology (31 citations). Xiaopeng Cui has collaborated with scholars based in China and United States. Frequent co-authors include Xianjuan Shen, Song He, Cuihua Lu, Runzhou Ni, Qing Ke, Aiguo Shen, Mudan Lu, Chun Cheng, Shaoqing Ju and Jinxia Liu. Their work appears in journals such as Medical Oncology, Experimental and Molecular Pathology, Pathology & Oncology Research, Journal of Molecular Histology and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.